Nikko Asset Management Americas, Inc. 13D and 13G filings for Pacific Biosciences of California, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 5:12 pm Sale |
2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Nikko Asset Management Americas, Inc. | 13,200,375 4.930% |
-965,818 (-6.82%) |
Filing |
| 2023-02-10 10:29 am Purchase |
2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Nikko Asset Management Americas, Inc. | 14,166,193 6.260% |
2,251,168 (+18.89%) |
Filing |
| 2022-02-14 06:05 am Purchase |
2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Nikko Asset Management Americas, Inc. | 11,915,025 5.400% |
11,915,025 (New Position) |
Filing |